Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Financial Overview
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H's market cap is currently HK$640.17M. The company's EPS TTM is HK$; its P/E ratio is -17.65; Tianjin TEDA Biomedical Engineering Co. Ltd. Class H is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.